Valuation: Merck & Co., Inc.

Market Cap 323B 280B 261B 239B 450B 30,806B 457B 3,065B 1,203B 15,411B 1,213B 1,186B 51,329B P/E 2026 *
79.8x
P/E 2027 * 15.5x
Enterprise Value 361B 313B 292B 267B 503B 34,443B 511B 3,427B 1,345B 17,231B 1,356B 1,326B 57,389B EV / Sales 2026 *
5.38x
EV / Sales 2027 * 4.98x
Free-Float
68.93%
Yield 2026 *
2.6%
Yield 2027 * 2.7%
Manager TitleAgeSince
Chief Executive Officer 59 2021-06-30
Director of Finance/CFO 57 2021-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 65 2007-11-26
Director/Board Member 73 1995-08-31
Chairman 59 2022-11-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%-1.93% - - 323B
+1.82%+2.47%+62.25%+24.01% 323B
-0.73%-3.07%+31.34%-13.14% 72.07B
-0.48%+24.74%+63.15%+133.07% 11.65B
+0.63%+1.87%-3.74%-3.95% 8.44B
+3.86%+13.14%-10.94%-11.03% 4.9B
-0.47%+24.45%+3.76%+50.57% 4.36B
+1.74%+11.41%-26.79%+12.70% 4.31B
-1.20%+2.33%+14.16%+48.07% 2.74B
+0.80%+0.63%+1.98%-0.53% 2.27B
Average +0.65%+328.87%+15.02%+26.64% 48.19B
Weighted average by Cap. +0.99%+171.96%+52.94%+20.01%

Financials

2026 *2027 *
Net sales 67.12B 58.1B 54.31B 49.64B 93.54B 6,401B 95B 637B 250B 3,202B 252B 247B 10,666B 70.32B 60.88B 56.9B 52B 98B 6,707B 99.53B 667B 262B 3,355B 264B 258B 11,175B
Net income 4.12B 3.57B 3.33B 3.05B 5.74B 393B 5.83B 39.09B 15.34B 197B 15.47B 15.13B 655B 20.31B 17.58B 16.44B 15.02B 28.31B 1,937B 28.75B 193B 75.63B 969B 76.27B 74.61B 3,228B
Net Debt 38.14B 33.02B 30.86B 28.21B 53.15B 3,637B 53.98B 362B 142B 1,820B 143B 140B 6,061B 27.01B 23.38B 21.85B 19.97B 37.64B 2,576B 38.23B 256B 101B 1,289B 101B 99.2B 4,292B
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (73.9%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (15.5%); - sale of animal health products (9.8%); - other (0.8%). Net sales are distributed geographically as follows: the United States (56.2%), Europe/Middle East/Africa (22.4%), Latin America (5.2%), Asia/Pacific (4.6%), Japan (4.2%), China (3%) and other (4.4%).
Employees
74,000
Calendar
08-13
Trader
Investor
Global
Quality
ESG MSCI
A